CRON vs MNMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CRON

60.3
AI Score
VS
MNMD Wins

MNMD

61.5
AI Score

Investment Advisor Scores

CRON

Aug 03, 2026
60score
Recommendation
BUY

MNMD

Aug 03, 2026
62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CRON MNMD Winner
Forward P/E 28.6533 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 40.1% 0.0% CRON
Earnings Growth 126.8% 0.0% CRON
Tradestie Score 60.3/100 61.5/100 MNMD
Profit Margin -1.1% 0.0% MNMD
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

CRON 1M: -1.0% · 3M: +6.0% MNMD 1M: +19.5% · 3M: +22.6%

Current Technical Phase

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.9% over 20 days), RSI 55

RSI (14): 54.7 · Price: $2.83

MNMD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 65

RSI (14): 65.3 · Price: $15.02

Fundamentals Snapshot

Metric CRON MNMD
Market Cap
Forward P/E 19.6 -8.5
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.4% 0.0%
Gross Margin 0.4%
Operating Margin 0.0% 0.0%
EPS 0.00 -1.98
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MNMD is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.